Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer

被引:6
|
作者
Hamester, Fabienne [1 ]
Stuerken, Christine [2 ,3 ]
Legler, Karen [1 ]
Eylmann, Kathrin [1 ]
Moller, Katrin [1 ]
Rossberg, Maila [1 ]
Gorzelanny, Christian [4 ]
Bauer, Alexander T. [4 ]
Windhorst, Sabine [5 ]
Schmalfeldt, Barbara [1 ]
Laakmann, Elena [1 ]
Muller, Volkmar [1 ]
Witzel, Isabell [1 ]
Oliveira-Ferrer, Leticia [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Martinistr 52, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Anat & Expt Morphol, Martinistr 52, D-20246 Hamburg, Germany
[3] Med Univ, Fac Med, MSH Med Sch Hamburg, D-20251 Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, Martinistr 52, D-20246 Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Signal Transduct, Martinistr 52, D-20246 Hamburg, Germany
关键词
breast cancer brain metastases; blood-brain barrier; pericellular Hyaluronan-coat; adhesion; invasion; CELL-LINES; SURVIVAL; BARRIER; MANAGEMENT; EXPRESSION; SINGLE;
D O I
10.3390/cells11203275
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Breast cancer (BC) is the second-most common cause of brain metastases (BM) and BCBM patients have a reduced quality of life and a poor prognosis. Hyaluronan (HA), and in particular the hyaluronidase Hyal-1, has been already linked to the development of BCBM, and therefore presents an interesting opportunity to develop new effective therapeutic options. HA metabolism was further discovered by the CRISPR/Cas9-mediated knockout of HYAL1 and the shRNA-mediated down-regulation of HA-receptor CD44 in the brain-seeking triple-negative breast cancer (TNBC) cell line MDA-MB-231-BR. Therefore, the impact of Hyal-1 on adhesion, disruption, and invasion through the brain endothelium, both in vitro and in vivo, was studied. Our analysis points out a key role of Hyal-1 and low-molecular-weight HA (LMW-HA) in the formation of a pericellular HA-coat in BC cells, which in turn promotes tumor cell adhesion, disruption, and migration through the brain endothelium in vitro as well as the extent of BM in vivo. CD44 knockdown in MDA-MB-231-BR significantly reduced the pericellular HA-coat on these cells, and, consequently, tumor cell adhesion and invasion through the brain endothelium. Thus, the interaction between Hyal-1-generated LMW-HA fragments and the HA-receptor CD44 might represent a potential target for future therapeutic options in BC patients with a high risk of cerebral metastases formation.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Triple-negative Breast Cancer is not Associated with Increased Nodal Metastases
    Gangi, A.
    Mirocha, J.
    Leong, T.
    Giuliano, A. E.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S57 - S57
  • [22] Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases
    Contreras-Zarate, Maria J.
    Day, Nicole L.
    Ormond, D. Ryan
    Borges, Virginia F.
    Tobet, Stuart
    Gril, Brunilde
    Steeg, Patricia S.
    Cittelly, Diana M.
    ONCOGENE, 2019, 38 (24) : 4685 - 4699
  • [23] Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases
    Maria J. Contreras-Zárate
    Nicole L. Day
    D. Ryan Ormond
    Virginia F. Borges
    Stuart Tobet
    Brunilde Gril
    Patricia S. Steeg
    Diana M. Cittelly
    Oncogene, 2019, 38 : 4685 - 4699
  • [24] The role of the immune system in triple-negative breast cancer
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2020, 24 (01) : 32 - 38
  • [25] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
    Savas, Peter
    Loi, Sherene
    CANCER CELL, 2020, 37 (05) : 623 - 624
  • [26] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [27] Triple-Negative Breast Cancer Role of the Androgen Receptor
    Gucalp, Ayca
    Traina, Tiffany A.
    CANCER JOURNAL, 2010, 16 (01): : 62 - 65
  • [28] Triple-Negative Breast Cancer Role of Antiangiogenic Agents
    Greenberg, Sally
    Rugo, Hope S.
    CANCER JOURNAL, 2010, 16 (01): : 33 - 38
  • [29] Role of mTOR inhibition in triple-negative breast cancer
    Massihnia, Daniela
    Bronte, Giuseppe
    Castiglia, Marta
    Barraco, Nadia
    Cangemi, Antonina
    Perez, Alessandro
    Fanale, Daniele
    Pantuso, Gianni
    Vieni, Salvatore
    Calo, Valentina
    Rolfo, Christian D.
    Bazan, Viviana
    Russo, Antonio
    CANCER RESEARCH, 2016, 76
  • [30] Role of flavonoids in inhibiting triple-negative breast cancer
    Wang, Shuai
    Wang, Kuanyu
    Li, Cheng
    Chen, Jing
    Kong, Xiangding
    FRONTIERS IN PHARMACOLOGY, 2024, 15